Immunomodulation by galectin-9: Distinct role in T cell populations, current therapeutic avenues and future potential

Eva M Gossink(University Medical Center Utrecht), Caroline A. Lindemans(University Medical Center Utrecht), Alessandro Cutilli(Utrecht University), Paul J. Coffer(Boston Children's Hospital)

Cellular Immunology

November 13, 2024

10.1016/j.cellimm.2024.104890

Cited by 14

Related Papers

Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration

|Nature|2015|1.1k

Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

|Nature Immunology|2016|727

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis

|Blood|2016|554

How I treat adenovirus in hematopoietic stem cell transplant recipients

|Blood|2010|231

γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia

|Leukemia|2013|186